Teleflex Incorporated (NYSE:TFX) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio reduced its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 37.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,952 shares of the medical technology company's stock after selling 9,725 shares during the period. Public Employees Retirement System of Ohio's holdings in Teleflex were worth $2,839,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Headlands Technologies LLC purchased a new stake in Teleflex during the fourth quarter worth about $29,000. True Wealth Design LLC increased its stake in Teleflex by 62.3% during the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock worth $48,000 after purchasing an additional 104 shares during the period. IFP Advisors Inc increased its stake in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after buying an additional 217 shares during the period. Exchange Traded Concepts LLC increased its stake in shares of Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after buying an additional 94 shares during the period. Finally, State of Wyoming purchased a new stake in shares of Teleflex during the fourth quarter worth approximately $62,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Stock Performance

Shares of TFX traded up $1.39 during mid-day trading on Wednesday, reaching $122.83. 376,076 shares of the company's stock were exchanged, compared to its average volume of 626,090. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market capitalization of $5.43 billion, a PE ratio of 24.42, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The business's fifty day simple moving average is $128.53 and its 200-day simple moving average is $156.02. Teleflex Incorporated has a 52-week low of $118.70 and a 52-week high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company's revenue for the quarter was down 5.0% compared to the same quarter last year. During the same period last year, the firm posted $3.21 earnings per share. On average, equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.11%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's dividend payout ratio is presently 42.90%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Morgan Stanley cut their target price on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research note on Monday, May 5th. Royal Bank of Canada cut their target price on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research note on Friday, May 2nd. Piper Sandler restated a "neutral" rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Raymond James lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Finally, Citizens Jmp lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.